Nina Niu Sanford, Assistant Professor and Chief of Gastrointestinal Radiation Oncology at Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital, posted on X:
“Save the best for last! My mentor Ted Hong discusses multimodal tx for optimizing immune response in mCRC.
Liver mets appear to decrease IO efficacy.
Look forward to upcoming Ph III RCT assessing addition of RT to stimulate immune response in MSS mCRC led by Aparna Raj Parikh.”
